First AD

Second AD

Lung Cancer

The OncLive Lung Cancer condition center page is a comprehensive resource for clinical news and expert insights on non–small cell lung cancer, small cell lung cancer, mesothelioma, and more. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in lung cancer.

Expanding Horizons: Antibody Drug Conjugates in Non-Small Cell Lung Cancer

Insights

Dr Wade Thomas Iams explains how trastuzumab deruxtecan became the standard-of-care for HER2-mutated non-small cell lung cancer.

HER2-Directed Agents in NSCLC

Overview of Antibody Drug Conjugates in Lung Cancer

ADCs in Development for the Treatment of Lung Cancer

Targeting CEACAM5 in Patients with Non-Small Cell Lung Cancer

Targeting HER3 in EGFR-Mutant NSCLC

Exploring TROP2 Expression in Patients with NSCLC